Cat Supplements care - Enisyl-f Syringe

It is estimated that at least 80% of all the cats in the world are infected with Feline Herpes Virus (FHV-1) which is a major cause of the most severe and widespread respiratory infection in cats, Feline Viral Rhinotracheitis (FVR). Up to 80% of cats who contract FHV-1 remain lifelong carriers of this highly contagious virus and can pass it on to uninfected cats through viral shedding. Reactivation of the virus may occur spontaneously throughout an infected catâ??s lifetime, although it is often associated with stress. FHV-1 presents a greater threat to kittens, in whom it causes severe respiratory and ocular symptoms. While mortality is generally low in adult cats, it can reach 30% in kittens. In adult cats, FHV-1 flare-ups are often hard to differentiate from the other two main feline infectious respiratory diseases, calicivirus and chlamydiosis. Clinical Symptoms & Diagnosis Acute attack of sneezing accompanied by nasal discharge Conjunctivitis and ocular involvement Varying degrees of decrease in general health Enisyl-F™ The first lysine-based supplement developed specifically for cats and kittens Highly palatable paste that is easily accepted by most cats Convenient dial-a-dose syringe for precise dosing and easy administration (which may help promote client compliance) Excellent safety profile Manufactured according to Good Manufacturing Practices (GMP) standards Cat & Kitten>Supplements

Description provided by the manufacturer or retailer